Finance

Lists
RUBICON:NSE
Rubicon Research Ltd
₹1,801.60
-2.14%
(-39.40) 1D
Aug 28, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
₹1,849.00
High
₹1,899.00
Low
₹1,796.20
Mkt. cap
298.22B
Avg. vol.
0.00
Volume
249.26K
Dividend
0.08%
Quarterly dividend
₹0.38
Ex-dividend date
Aug 7, 2026
P/E ratio
103.22
52-wk high
₹1,899.00
52-wk low
₹570.75
EPS
₹17.45
No. of employees
1K
Open
₹1,849.00
High
₹1,899.00
Low
₹1,796.20
Mkt. cap
298.22B
Avg. vol.
0.00
Volume
249.26K
Dividend
0.08%
Quarterly dividend
₹0.38
Ex-dividend date
Aug 7, 2026
P/E ratio
103.22
52-wk high
₹1,899.00
52-wk low
₹570.75
EPS
₹17.45
No. of employees
1K
News stories
From web sources and news partners
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1.29K
Founded1999
Headquarters-
SectorPharmaceutical industry
Websiterubicon.co.in
Last report
Aug 14, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹5.08 / ₹4.40
+15.45%beat
Revenue / Est. (INR)
5.34B / 5.13B
+4.20%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.52B
4.12B
4.76B
5.14B
Cost of goods sold
1.06B
1.27B
1.57B
1.86B
Cost of revenue
1.06B
1.27B
1.57B
1.86B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
584.80M
633.59M
663.73M
699.04M
Operating expense
1.81B
2.03B
2.22B
2.21B
Total operating expenses
2.87B
3.30B
3.79B
4.07B
Operating income
658.68M
824.26M
965.73M
1.06B
Other non operating income
-19.44M
6.97M
37.87M
-157.07M
EBT including unusual items
595.56M
717.05M
905.86M
986.87M
EBT excluding unusual items
595.56M
717.05M
905.86M
996.82M
Income tax expense
162.55M
178.53M
177.89M
219.02M
Effective tax rate
27.29%
24.90%
19.64%
22.19%
Other operating expenses
1.12B
1.28B
1.44B
1.39B
Net income
433.01M
538.52M
727.97M
767.85M
Net profit margin
12.28%
13.07%
15.31%
14.94%
Earnings per share
-
3.47
4.41
4.60
Interest and investment income
3.24M
-
-
79.68M
Interest expense
-85.10M
-114.18M
-97.74M
-
Net interest expenses
-81.86M
-114.18M
-97.74M
79.68M
Depreciation and amortization charges
95.72M
118.71M
115.53M
122.66M
EBITDA
720.55M
976.82M
1.12B
1.14B
Gain or loss from assets sale
-
7.63M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps